Ashish Ipe Koshy
About
Ashish Ipe Koshy is from Abu Dhabi Emirate, United Arab Emirates. Ashish is currently Chief Executive Officer at Inception42, located in United Arab Emirates. In Ashish's previous role as a Chief Operating Officer at Inception, Ashish worked in Abudhabi until May 2025. Prior to joining Inception, Ashish was a Board Member at Cleveland Clinic Abu Dhabi and held the position of Board Member at Abu Dhabi Emirate, United Arab Emirates. Prior to that, Ashish was a Chairman of the Board at Malaffi (Abu Dhabi Health Information Exchange), based in Abudhabi from Mar 2023 to Sep 2024. Ashish started working as Co-Founder & Group Chief Operating Officer at M42 Health in Abu dhabi in Jan 2023. From Jan 2017 to Dec 2022, Ashish was Founder & CEO - G42 Healthcare at G42 Healthcare, based in Abu Dhabi, United Arab Emirates. Prior to that, Ashish was a Deputy General Manager - Technology Development & Innovation at Jio, based in India from Jan 2015 to Jan 2017. Ashish started working as Technology Planning at Ooredoo Group in Kuwait in Jan 2009.
Go to finalscout.com and type Ashish Ipe Koshy's name into the search box for a free email address. FinalScout is a professional database with more than 500 million business professionals and 200 million company executives.
Ashish Ipe Koshy's current jobs
Ashish Ipe Koshy's past jobs
Inception is a G42 company that is purely focused on building AI native commercial applications for enterprise needs across industries, providing: - AI Factory - Responsible AI and AI Consulting - Custom AI models as a service - Enterprise AI agentic platforms
Malaffi is an innovative, regions first, unified health information exchange platform that facilitates a more patient-centric approach to healthcare provision. Malaffi enables healthcare facilities, healthcare professionals and government authorities across the Emirate of Abu Dhabi to access and share patients’ medical information in order to deliver better healthcare quality and enhance patient safety and overall health outcomes.
M42 was created with the merger of G42 Healthcare and Mubadala Health, the company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. M42 is a global tech-enabled healthcare company operating at the forefront of medical advancement.By harnessing innovative solutions, unique medical and data-centric technologies, including genomics and AI, M42 is also transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care. M42 has over 20,000 employees and more than 450 facilities in 24 countries around the world, it is a first-of-its-kind integrated healthcare company that combines unique medical and data-centric technologies with state-of-the-art facilities to deliver world-class care. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence, Abu Dhabi Health Data Services (Malaffi) and National Reference Laboratory, among others.
G42 Healthcare, a leading health-tech company, is on a mission to develop a world-class healthcare sector in the UAE and beyond, by harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care and transforming the traditional healthcare ecosystem. At the forefront in the battle against COVID-19, we have established Biogenix Labs, UAE’s first COVID-19 accredited large-scale throughput laboratory, facilitated the 4Humanity clinical trials, the world’s first phase three trial for inactivated vaccine against COVID-19 with over 43,000 volunteers from 125+ nationalities across the pan-Arab region, supported UAE’s healthcare authorities on the national vaccination implementation, employed advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conducted research into new vaccines and drug therapies, and built Omics Centre of Excellence, the region’s largest and most technologically advanced omics facility that is the backbone for the Emirati Genome Program, the world’s most comprehensive population genomics initiative. Beyond COVID-19 we have plans and R&D encompassing genomics, imaging and diagnostics, and digitization programs to support the health of future generations. At G42 Healthcare, our plans are large in scale and bold in ambition. We partner extensively with governments, leading international entities, scientists and researchers and the wider medical community who subscribe to our values and our mission as we develop solutions to future-proof the health of nations.
India's largest telecom operator
Ooredoo is an award-winning international communications company operating across the Middle East, North Africa and Southeast Asia. Serving consumers and businesses in 10 countries, we deliver a leading data experience through a broad range of content and services via our advanced, data-centric mobile and fixed networks. With a customer base of more than 138 million people, we work hard to provide the best customer and network experience we can. We believe in the power of mobile technology to bring about social and economic progress.